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Background: 
Remote ischaemic per-conditioning (RIC) in experimental ischaemic stroke is 
neuroprotective. Several neurohumoral, vascular and inflammatory mediators 
are implicated. 
 
Methods:  
The REmote ischaemic Conditioning After Stroke Trial (RECAST) was a pilot 
blinded sham-controlled trial in patients with ischaemic stroke, randomised to 
receive four 5-minute cycles of RIC within 24 hours of ictus. Plasma taken pre-
intervention, immediately post-intervention and on day 4 was analysed for nitric 
oxide (nitrate/nitrite) levels using chemiluminescence and other biomarkers 
were analysed by enzyme-linked immunosorbent assay (ELISA): alpha-2-
macroglobulin (A2M), serum amyloid protein (SAP), e-selectin, vascular 
endothelial growth factor (VEGF).  Biomarkers were correlated with outcome 
(Day 90 National Institutes of Health Stroke Scale [NIHSS], modified Rankin 
scale [mRS], Barthel index [BI]) using Pearson’s correlation coefficient. 
 
Results:  
In all 26 patients, an increase in SAP (pre- to post-intervention) positively 
correlated with worse day 90 mRS (r=0.429, p=0.029) and negatively with 
worse BI (r=-0.392, p=0.048), whilst an increase in SAP from day 0 to 4 
positively correlated with worse day 90 NIHSS (r=0.400, p=0.043), mRS 
(r=0.505, p=0.008) and negatively with worse BI (r=-0.439, p=0.025). RIC 
reduced SAP levels from pre- to post-intervention (n=13, 2-way ANOVA, 
p<0.05), whilst sham did not. No significant changes over time or by treatment, 
or correlations with outcome were seen for A2M, e-selectin, nitric oxide or VEGF. 
 
Conclusion:  
Increased plasma levels of SAP are associated with worse clinical outcomes after 
ischaemic stroke. RIC reduced SAP levels from pre- to post-intervention. Larger 
studies assessing biomarkers and efficacy of RIC in acute ischaemic stroke are 
warranted.   
